DBV Technologies (DBVT) Prepaid Assets (2015 - 2026)
DBV Technologies (DBVT) posted Prepaid Assets of $27.0 million for Q2 2026, up 54.29% sequentially from $17.5 million in Q1 2026, and up 49.72% YoY from $18.0 million in Q2 2025.
DBV Technologies (DBVT) Prepaid Assets (2015 - 2026) Analysis & Trends
DBV Technologies has reported Prepaid Assets for 12 years, with the latest figure at $27.0 million in Q2 2026.
- Quarterly Prepaid Assets rose 49.72% year-over-year to $27.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $27.0 million (up 49.72% YoY) and the FY2025 annual result came in at $18.8 million, up 57.56% from the prior year.
- Prepaid Assets improved to $27.0 million in Q2 2026 per DBVT's latest filing, from $17.5 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $27.0 million in Q2 2026 and troughed at $11.9 million in Q4 2024.
- A 5-year average of $18.1 million and a median of $18.0 million in 2023 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 122.19% in 2022, down 62.57% in 2022.
- Over 5 years, Prepaid Assets stood at $13.9 million in 2022, then advanced by 26.43% to $17.5 million in 2023, then tumbled by 32.0% to $11.9 million in 2024, then surged by 57.56% to $18.8 million in 2025, then surged by 43.62% to $27.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $27.0 million, $17.5 million, and $18.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.00 Mn |
| Mar 31, 2026 | 17.50 Mn |
| Dec 31, 2025 | 18.80 Mn |
| Sep 30, 2025 | 19.05 Mn |
| Jun 30, 2025 | 18.03 Mn |
| Mar 31, 2025 | 16.19 Mn |
| Dec 31, 2024 | 11.93 Mn |
| Sep 30, 2024 | 22.32 Mn |
| Jun 30, 2024 | 23.75 Mn |
| Mar 31, 2024 | 18.04 Mn |
| Dec 31, 2023 | 17.55 Mn |
| Sep 30, 2023 | 20.14 Mn |
| Jun 30, 2023 | 21.58 Mn |
| Mar 31, 2023 | 17.95 Mn |
| Dec 31, 2022 | 13.88 Mn |
| Sep 30, 2022 | 13.03 Mn |
| Jun 30, 2022 | 11.98 Mn |
| Mar 31, 2022 | 16.33 Mn |
| Dec 31, 2021 | 37.09 Mn |
| Sep 30, 2021 | 11.94 Mn |